Viewing Study NCT00363168


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-02 @ 10:19 PM
Study NCT ID: NCT00363168
Status: COMPLETED
Last Update Posted: 2012-10-19
First Post: 2006-08-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial
Sponsor: Johns Hopkins University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Choroidal Neovascularization View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hemorrhagic Choroidal Neovascularization View